O1‐08‐02: DEVELOPMENT OF TREM2 AGONISTIC ANTIBODIES TO TREAT ALZHEIMER'S DISEASE

作者
Tina Schwabe,Ilaria Tassi,Hervé Rhinn,Adiljan Ibrahim,Philip L. Kong,Santiago V. Salazar,Seungjoo Lee,Arnon Rosenthal
出处
期刊:Alzheimers & Dementia [Wiley]
卷期号:15 (7S_Part_4)
标识
DOI:10.1016/j.jalz.2019.06.4560
摘要

Recent human genetic studies have revealed that dysfunction in microglia is associated with the development of Alzheimer's disease (AD), and that the receptor TREM2 is a key regulator of microglial activity. Mutations in TREM2 that reduce its function increase the risk of developing AD while complete loss of TREM2 causes a rare neurodegenerative disorder, demonstrating the importance of TREM2-mediated microglial activity in maintaining functionality of the aging brain. TREM2 is an immune cell activating receptor that binds ligands exposed by apoptotic neurons, degrading myelin or amyloid plaques. Loss of TREM2 signaling causes reduced microglial viability, proliferation and activation. We sought to develop TREM2 agonistic antibodies to increase TREM2 signaling in AD patient brains to improve the ability of microglia to clear pathological proteins and protect neurons with the goal to halt progression of the disease. We utilized hybridoma and Adimab yeast platforms to identify TREM2 binding antibodies. Antibodies were screened for their ability to activate TREM2 signaling in a reporter cell assay and primary myeloid cells in vitro, as well as for their ability to activate signaling in vivo. To test the effects of TREM2 antibodies on brain microglia, they were injected peripherally into mice expressing human TREM2. Microglial proliferation and abundance was assessed by immunohistochemistry and tissue RNAseq. Finally, TREM2 antibodies were chronically administered to 5xFAD AD model mice to test if TREM2 activation can impact AD pathology. We have identified antibodies that activate TREM2 signaling both in a reporter cell assay and in macrophages in vitro. Peripheral injection of these antibodies triggers TREM2 signaling, microglial proliferation and activation in mouse brains. These data suggest that the antibodies efficiently cross the blood-brain barrier and that TREM2 signal induction is sufficient to shift the microglia phenotype. In 5xFAD mice, chronic treatment with a TREM2 agonist causes increased expression of synaptic and myelin genes. Our data suggest that TREM2 agonistic antibodies could reverse microglial dysfunction in AD patients. Alector's lead antibody AL002 is currently in phase I clinical trials, being assessed for safety, PK and brain target engagement in healthy subjects and AD patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
DOC_XIONG的应助被皮皮猪大王采纳,获得10
刚刚
赘婿的应助被优美的剑采纳,获得10
刚刚
刚刚
Rex关闭了Rex的文献求助
刚刚
复杂雪一完成签到,获得积分10
1秒前
NexusExplorer的应助被朱xxa采纳,获得10
2秒前
2秒前
ph0307发布了新的文献求助10
2秒前
开心聪展完成签到,获得积分10
2秒前
dog发布了新的文献求助10
2秒前
2秒前
3秒前
Paranoid完成签到,获得积分10
3秒前
子岚完成签到,获得积分10
4秒前
钱钱完成签到,获得积分10
4秒前
ququ完成签到 ,获得积分20
4秒前
4秒前
xxmxyf发布了新的文献求助10
4秒前
4秒前
南笙几梦完成签到,获得积分10
4秒前
鲸落发布了新的文献求助10
5秒前
BigBeen完成签到 ,获得积分10
5秒前
阔达的问芙完成签到,获得积分10
5秒前
玛卡巴卡的应助被Bruce采纳,获得10
5秒前
eth05med发布了新的文献求助10
6秒前
6秒前
1290qw完成签到,获得积分10
6秒前
在这完成签到,获得积分10
6秒前
adi完成签到 ,获得积分10
6秒前
star完成签到,获得积分10
7秒前
思念是什么味道完成签到,获得积分10
7秒前
工作热情仔的应助被yyds采纳,获得30
7秒前
冲就完了发布了新的文献求助10
7秒前
李健的应助被肉丸子采纳,获得10
7秒前
mkl发布了新的文献求助10
7秒前
7秒前
8秒前
Caicai发布了新的文献求助10
8秒前
obito完成签到,获得积分10
8秒前
阿白完成签到 ,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180531
求助须知:如何正确求助?哪些是违规求助? 9570507
关于积分的说明 21812974
捐赠科研通 7776619
什么是DOI,文献DOI怎么找? 3433286
关于科研通互助平台的介绍 2557539
邀请新用户注册赠送积分活动 2479185